Tang Capital Management
$2.2B 13F equity value
55 Holdings
Quarter ended June 30, 2026
The latest 13F on file for Tang Capital Management covers the quarter ended June 30, 2026. Institutional managers report holdings quarterly to the SEC, so each filing is a snapshot of positions held on that date.
Top Holdings
| Ticker | Company | Shares | Value | Weight |
|---|---|---|---|---|
| AUPH | AURINIA PHARMACEUTICALS INC | 13,044,106 | $221M | 10.1% |
| SYRE | SPYRE THERAPEUTICS INC | 1,892,200 | $168M | 7.7% |
| MIRM | MIRUM PHARMACEUTICALS INC | 1,236,027 | $145M | 6.6% |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 2,259,889 | $145M | 6.6% |
| CELC | CELCUITY INC | 1,314,594 | $138M | 6.3% |
| CORT | CORCEPT THERAPEUTICS INC | 1,500,000 | $130M | 6.0% |
| PTCT | PTC THERAPEUTICS INC | 1,500,000 | $122M | 5.6% |
| LKFT | LAKEFRONT BIOTHERAPEUTICS NV | 3,785,991 | $114M | 5.2% |
| CAPR | CAPRICOR THERAPEUTICS INC | 4,099,900 | $99M | 4.5% |
| TARS | TARSUS PHARMACEUTICALS INC | 1,568,266 | $99M | 4.5% |
Track Tang Capital Management's 13F portfolio: $2.2B in reported holdings, 55 positions. Top holdings and quarterly changes on SentiSense.
This page is powered by the SentiSense API: GET /api/v1/institutional/institution/{slugOrCik}